Cassava Sciences
SAVA
#9461
Rank
C$0.16 B
Marketcap
C$3.37
Share price
12.26%
Change (1 day)
29.91%
Change (1 year)

Earnings for Cassava Sciences (SAVA)

Earnings in 2025 (TTM): -C$0.16 Billion

According to Cassava Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$0.21 Billion a decrease over its 2023 earnings that were of -C$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cassava Sciences from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.16 Billion-22.07%
2024 -C$0.21 Billion34.28%
2023 -C$0.16 Billion32.41%
2022 -C$0.12 Billion143.46%
2021 -C$46.59 Million383.92%
2020 -C$9.63 Million36.96%
2019 -C$7.03 Million-25.56%
2018 -C$9.45 Million-44.25%
2017 -C$16.94 Million-20.11%
2016 -C$21.21 Million5.32%
2015 -C$20.13 Million14.23%
2014 -C$17.63 Million-139.64%
2013 C$44.45 M
2010 -C$19.43 Million102.87%
2009 -C$9.58 Million-177.52%
2008 C$12.34 M-14.32%
2007 C$14.41 M-1942.21%
2006 -C$0.79 Million
2004 -C$55.23 Million75.1%
2003 -C$31.54 Million
2001 -C$24.55 Million20.49%
2000 -C$20.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.21 Billion 27.50%๐Ÿ‡บ๐Ÿ‡ธ USA